Premaitha Share Discussion Threads

[dave444] 03/10/2017 10:29

It would appear the go live date for NSC is October 2018

[the monkster] 02/10/2017 22:56

Forget the share price its the story posters here seem more content with. 6p soon but it's a great prospect.

[thinkbig?] 02/10/2017 08:52

And the dumping continues. All the sign of the people in the know. That fund raising is coming. At a lot lower Price.

[head gardener] 29/9/2017 18:17

The global growth achieved must be of some interest to illumina ,trying to break the company through litigation has not stalled growth.

[dj trading] 29/9/2017 18:07

Further point re cash
The cash burn for 16/17 included £2.1m relating to litigation (see movement in provision)
At year end the provision stood at £3.3m and all within current liabilities so they expect all of this will be expended in 2017/18FY with I assume the bulk in 1H as court case was in July.
Whilst this has been provided for through the P&L there isn't a cash reserve so cash burn in 1H likely to be higher than the typical run rate - offset by increased Revenue/GP.
So further TF loan/fundraise very likely before Xmas imo
As a personal view I suppose it makes sense to defer as long as possible. If they win court case then cash problem relieved to some degree, if they lose then any cash raised might just go to pay fees and costs etc. dyor etc.

[dibs61] 29/9/2017 15:43

DJ Trading (I think your username says it all lol!)

Your comments are worthy and reasonable. However the court case issues are NOT preventing expansion or growth which is now clearly steaming ahead. At some point the market will be unable to ignore this any longer or at least begin to disregard it as the company de risks through major diversification into high growth unaffected regions. This is plainly happening already. In a years time a court case win would simply be icing on top of the cake.

[twix386] 29/9/2017 15:28

That's by financial year end - 31/3/18

[hjb1] 29/9/2017 15:16

this court case could take so long that UK/Europe won't matter that much in a couple of years time.Europe is a very slow burner compared to other parts of the world and that's where they're at.They still reckon to be b/e or a positive position by year end though.

[dj trading] 29/9/2017 14:04

Whilst reading the results looking for commentary on the current cash position I noted this in the financial commentary
"However, there is significant uncertainty over the outcome of the trial, which is expected to be received in Autumn 2017, and any potential cost awards or appeal costs arising. Any appeal by either party, if granted by the Court, is likely to take over 12 months to complete and any estimates would be purely speculative at this time."

Also worth carefully reading Note 2 to the accounts "Going concern"

[dj trading] 29/9/2017 13:08

Revenue and cashburn £m/6month for past 2 years

.......1H16 2H16 1H17 2H17
Revenue 0.6 1.8 1.45 1.6
Cashburn 4.4 3.8 3.7 4.2

Year end cash 31/3/17 was £1.3m and since then they have extended TF loan by $4-5m
So assuming burn rate still running at around £4m/6month they will be looking for a further loan/funds before Xmas
dyor

[twodegrees] 29/9/2017 12:12

thinkbig, surely after all the sells at such lows, good news today, this should be climbing off its lows...in any case why would we have a seller when news is good, seems barmy to me......... anyone got level 2..how many market makers do we have...what is the company doing about PR.

[thinkbig?] 29/9/2017 11:50

Still seller there. Need someone to take his shares. All them 6p shares getting 8p nice profit

[captain_kurt] 29/9/2017 10:09

And that's how you make money, at times like these when the market gets it wrong. share price won't be this low for long imo

[dibs61] 29/9/2017 09:53

Market still doesn't want to know despite all the evidence to the contrary

[philjeans] 29/9/2017 09:34

Excellent report - good time to BUY down here.

[twodegrees] 29/9/2017 08:29

God news for a change...steady increase in sales and profit.

[captain_kurt] 29/9/2017 07:39

Sales beginning to soar upwards in this financial year and company confident (as I am) that the litigation - whatever the result - is not going to ruin this company!!!

[captain_kurt] 29/9/2017 07:38

There is the reason for the buys

Profitable in current financial year.

Some serious growth,

Should lay the marker of a triple bottom with the those impressive results

[the monkster] 28/9/2017 21:56

indeed. up 0.12p - heady times

[thinkbig?] 28/9/2017 17:58

Looks like we might finally have a buyer. ???

[hjb1] 25/9/2017 23:49

Illumina Blasts Ariosa’s $100M Counterclaim In Patent Suit
Share us on:

By Nicole Narea
Law360, New York (September 5, 2017, 8:46 PM EDT) -- Genomics company Illumina Inc. accused rival Ariosa Diagnostics Inc. on Friday of violating California’s anti-SLAPP law by bringing $100 million in counterclaims in Illumina’s patent infringement suit, while Ariosa argued for its part Friday that its prenatal testing services plainly did not infringe.

In one of two motions filed by Illumina in California federal court Friday, the company argued that Ariosa filed its counterclaims for breach of contract in a “retaliatory” manner, threatening Illumina’s right to petition before the court in violation of a state law barring so-called strategic lawsuits against public participation.

“This is an extraordinary attempt to prevent Illumina from [pursuing] its patent infringement claim by alleging that access to the court is precluded because of Ariosa’s allegation that it has a license,” Illumina said in its anti-SLAPP motion. “The California Legislature enacted the anti-SLAPP statute precisely to put an end to retaliatory lawsuits such as this, which are based on a party’s valid exercise of its rights to petition for the redress of grievances.”

Illumina’s other motion, for summary judgment, attacked Ariosa’s counterclaims on the merits, as well as Ariosa’s attempt to invalidate a patent invented by its own founders and later assigned to Illumina.

Meanwhile, Ariosa filed its own summary judgment motion Friday in an effort to defeat Illumina’s infringement claims, arguing that its prenatal testing service did not perform various steps in the DNA analysis required by the the Illumina patent.

Counsel for Illumina did not immediately respond to a request for comment Tuesday, and counsel for Ariosa declined to comment.

Illumina’s suit targets Ariosa’s noninvasive “Harmony Prenatal Test” for genetic disorders, which it began offering in early 2012 using DNA sequencing technology provided by Illumina under a three-year agreement.

In early 2013, Illumina bought another competitor in the space, Verinata Health Inc., acquiring its noninvasive prenatal testing patents in the process. But Verinata had already accused Ariosa of infringing those patents, and Illumina said it then determined that Ariosa was also infringing its own patent on a technique for analyzing hundreds of DNA sequence fragments at the same time. Illumina said it notified Ariosa of its alleged infringement and attempted to negotiate to no avail.

[hjb1] 23/9/2017 10:11

well I expect you to make a profit on your shares so hang around a little longer.

[the monkster] 23/9/2017 08:19

Lol. We'll see. What on earth are you guys looking for here 30/40p ??? Dream on....

[small crow] 23/9/2017 06:28

"..and if we ever see that again I won't be here to see it." Match of the Day stuff that.

[hjb1] 22/9/2017 21:46

why, is your demise expected before xmas?